The total return over the past 12 months is +43.02% vs. +22.54% for the S&P 500. So far it's up +13.25% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +38.20% | (21.52%) | (17.24%) | +2.77% | N/A | N/A |
| Total Return CAGR | +43.02% | (19.48%) | (15.40%) | +4.74% | N/A | N/A |
| Revenue CAGR | (0.23%) | (1.94%) | (0.02%) | +2.86% | +4.73% | +6.62% |
| Net Income CAGR | (67.33%) | (41.44%) | (30.44%) | (11.53%) | (3.17%) | (0.20%) |
| EPS CAGR | (65.70%) | (25.93%) | (18.88%) | +2.16% | (5.83%) | (1.75%) |
| Free Cash Flow CAGR | +133.40% | +0.60% | (14.35%) | +0.62% | +4.34% | +8.21% |
| Operating Cash Flow CAGR | +38.49% | (5.30%) | (10.82%) | +2.14% | +5.24% | +8.40% |
| Dividends CAGR | 0.00% | (17.01%) | +2.71% | +7.18% | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
NRC Health (NRC)
| Year | Start price | End price | NRC Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $18.77 | $20.90 | +13.25% | +13.96% | (0.71%) |
| 2025 | $17.64 | $18.77 | +10.08% | +17.72% | (7.64%) |
| 2024 | $39.56 | $17.64 | (54.49%) | +24.89% | (79.38%) |
| 2023 | $37.30 | $39.56 | +7.26% | +26.19% | (18.93%) |
| 2022 | $41.52 | $37.30 | (8.21%) | (18.17%) | +9.96% |
| 2021 | $42.75 | $41.52 | (1.83%) | +28.74% | (30.57%) |
| 2020 | $65.94 | $42.75 | (34.86%) | +18.37% | (53.23%) |
| 2019 | $38.14 | $65.94 | +75.47% | +31.22% | +44.25% |
| 2018 | $37.30 | $38.14 | +5.36% | (4.56%) | +9.92% |
| 2017 | $19.00 | $37.30 | +99.11% | +21.70% | +77.41% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
